Cases & Deals

Boehringer Ingelheim Pharmaceuticals obtains dismissal of antitrust claims alleging sham litigation, brought by direct and indirect purchasers

Clients Boehringer Ingelheim Pharmaceuticals, Inc.

On behalf of Boehringer Ingelheim Pharmaceuticals, Inc., Jones Day obtained dismissal of direct and indirect purchaser class actions in cases alleging that Boehringer brought sham litigation to maintain an unlawful monopoly.

Carver v. Boehringer Ingelheim Pharmaceuticals, Inc., et al., No. 09-1044 (W.D. Pa.), and Meijer, Inc. v. Boehringer Ingelheim Pharmaceuticals, Inc., et al., No. 09-cv-01085 (W.D. Pa.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.